Canada Cancer Diagnostics Market to be Led by Consumables Through 2028

The increasing number of diagnostic centers is expected to drive the Canada cancer diagnostics market during the forecast period.

According to the TechSci Research report, “Canada Cancer Diagnostics Market - By Region, Competition, Forecast and Opportunities, 2028”, the market is anticipated to grow at an impressive rate during the forecast period, due to technological advancements in diagnostic testing techniques and the rise in strategic collaboration associated with cancer diagnostics products across the region. Additionally, the increasing number of programs to increase awareness about malignant tumor screening in numerous organizations and the surge in the number of testing kit launches are likely to escalate the growth of the Canada cancer diagnostics market in the coming years. Besides, increased screening for early diagnosis and to help existing patients along with growing research and development activities are expected to support the Canada Cancer Diagnostics market growth in the long run.

However, despite the growing demand for advanced cancer diagnostic tools, many Canadian healthcare facilities lack access to the latest technologies, which can create affordability issues, thereby slowing down the Canada cancer diagnostics market during the forecast period.

Similarly, in Canada, long wait times for cancer diagnostic tests are a significant problem that may hamper the Canada Cancer Diagnostics market growth in the near future. Also, the lack of standardization in cancer diagnostics across the country can result in inconsistencies in patient care and outcomes, which can further restrict the growth of the market.

Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on the "Canada Cancer Diagnostics Market.”

Canada cancer diagnostics market can be segmented by product, technology, application, end user, and region. Based on product, the Canada cancer diagnostics market is divided into Consumables v/s Instruments. The consumables segment dominated the Canada cancer diagnostics market in 2022 and is expected to continue maintaining its dominance throughout the forecast period. This can be ascribed to Increasing usage of consumables, increased R&D expenditure, an increase in the geriatric population, and the launch of technologically advanced diagnostic kits and reagents across the region.

Based on technology, the Canada cancer diagnostics market can be segmented into IVD testing, imaging, and biopsy. The IVD testing segment is expected to dominate the Canada cancer diagnostics market during the forecast period on account of the Increasing number of in-vitro diagnostics products being launched by the major players and growing awareness about associated benefits, such as faster recovery times, smaller incisions, and reduced pain and scarring further propel investment in this segment.

Major companies operating in the Canada cancer diagnostics market are:

• GE Healthcare Canada Inc
• Becton Dickinson Canada Inc.
• Roche Diagnostics Corp
• Abbott Medical Canada Inc
• FUJIFILM Canada Inc.
• Hologic Inc.
• Agilent Technologies Canada Inc.

Download Free Sample Report

Customers can also request 10% free customization on this report.

“The Canada cancer diagnostics market is expected to witness significant growth during the forecast period on account of the increasing strategic activities by key players and growing acquisition for complements the company’s competencies in NGS-based cancer diagnostics and provide the company with advanced technology for serving the needs of precision medicine across the region.

Furthermore, the rise in cervical screening programs conducted to increase awareness and screening, a rise in R&D, and technological advancements are further contributing to the demand for cancer diagnostics in Canada. Besides, the rising number of research activities undertaken by various academic and research organizations is further expected to create lucrative opportunities for market players during the forecast period,” said Mr. Karan Chechi, Research Director at TechSci Research, a research-based global management consulting firm.

Canada Cancer Diagnostics Market, By Product (Consumables, Instruments), Technology (IVD Testing, Imaging, Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Others), End User (Hospitals & Clinics, Diagnostic Laboratories, Others), Region and Competition, Forecast & Opportunities, 2028 has evaluated the future growth potential of Canada cancer diagnostics market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the Canada cancer diagnostics market.